Your browser doesn't support javascript.
loading
Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial.
Ter Veer, Emil; Prinsen, Hetty; Sprangers, Mirjam A G; Zwinderman, Koos A H; Bleijenberg, Gijs; van der Pouw Kraan, Tineke C T M; de Vries, I Jolanda M; Wierenga, Eddy A; van Laarhoven, Hanneke W M.
Afiliação
  • Ter Veer E; a Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Department of Medical Oncology, Academic Medical Center , Meibergdreef 9 , Amsterdam , the Netherlands.
  • Prinsen H; b Department of Radiology and Biomedical Imaging , Yale University , New Haven , Connecticut , USA.
  • Sprangers MAG; c Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Department of Medical Psychology, Academic Medical Center , Meibergdreef 9 , Amsterdam , the Netherlands.
  • Zwinderman KAH; d Amsterdam University Medical Centers, University of Amsterdam, Department of Clinical Epidemiology, Biostatistics & Bioinformatics, Meibergdreef 9 , Amsterdam , the Netherlands.
  • Bleijenberg G; e Expert Centre for Chronic Fatigue , Radboud University Nijmegen Medical Centre , Nijmegen , the Netherlands.
  • van der Pouw Kraan TCTM; f Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology , VU University Medical Center , Amsterdam , the Netherlands.
  • de Vries IJM; g Department of Tumor Immunology , Radboud University Nijmegen Medical Centre , Nijmegen , the Netherlands.
  • Wierenga EA; h Amsterdam University Medical Centers , University of Amsterdam, Department of Experimental Immunology, Academic Medical Center , Amsterdam , the Netherlands.
  • van Laarhoven HWM; a Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Department of Medical Oncology, Academic Medical Center , Meibergdreef 9 , Amsterdam , the Netherlands.
Cancer Invest ; 36(7): 371-377, 2018.
Article em En | MEDLINE | ID: mdl-30188739
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Quimiocina CXCL10 / Fadiga / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Invest Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Quimiocina CXCL10 / Fadiga / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Invest Ano de publicação: 2018 Tipo de documento: Article